REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
23/03/2026
Voltar para busca
Dado oficial do USPTO
XIIDRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
24/03/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
29/06/2020
Data de registro
23/03/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/03/2021
Última transação
24/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
77
Localização do titular
IE
Examinador
MAYES, LAURIE ANN
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "xiidra" in lower-case letters beneath a design suggestive of a stylized eye lens formed by a shaded crescent shape in between two upwardly curved lines.
Titulares e representantes
Titulares
Bausch + Lomb Ireland Limited
NOVARTIS AG
Representantes
Nancy L. Rowe Bausch + Lomb
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/03/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/03/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/07/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/07/2021
FIMP
FINAL DISPOSITION PROCESSED
02/07/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
23/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
23/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
11/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/01/2021
PUBO
PUBLISHED FOR OPPOSITION
05/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/12/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/11/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/11/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/11/2020
RFNT
REFUSAL PROCESSED BY IB
09/11/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
19/10/2020
RFRR
REFUSAL PROCESSED BY MPU
19/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/10/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
02/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/10/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/09/2020
CNRT
NON-FINAL ACTION WRITTEN
24/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
19/09/2020
DOCK
ASSIGNED TO EXAMINER
18/09/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
14/09/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/09/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace XIIDRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.